X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Quarterly Results   (ALKE)

Here are the latest quarterly results of . For more details, see the financial fact sheet and share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-16
*
3
Jun-16
*
3
Dec-16
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m11,42614,57912,747 
Other income Rs m426281330 
Turnover Rs m11,85214,85913,078 
Expenses Rs m9,84511,86810,394 
Gross profit Rs m1,5742,6662,319 
Depreciation Rs m260230244 
Interest Rs m107100170 
Profit before tax Rs m1,6332,6182,235 
Tax Rs m1,066230345 
Profit after tax Rs m5672,3881,889 
Gross profit margin %13.818.318.2 
Effective tax rate %65.38.815.5 
Net profit margin %5.016.414.8 
Diluted EPS Rs 4.7 20.0 15.8  
Diluted EPS (TTM) Rs NA NA NA  
 Subscriber Feature        
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   GSK PHARMA  FDC LTD.  ASTRAZENECA PHARMA  LUPIN LTD  FRESENIUS KABI ONCO.  

Compare ALKEM LABORATORIES With:   GSK PHARMA  FDC LTD.  ASTRAZENECA PHARMA  LUPIN LTD  FRESENIUS KABI ONCO.  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

World Stocks Mixed as Global Market Rally Loses Momentum(RoundUp)

Global financial markets ended the week on a mixed note. In the US, the Dow industrials ended the week down 0.4%, while the S&P 500 declined 0.1%.

Views on news

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

More Views on News

Most Popular

The Real Brave-hearts are Those Who Still Have Deposits in IDBI Bank(Vivek Kaul's Diary)

Nov 6, 2017

It makes no sense to continue banking with this bank.

'Buy and Hold Forever' Not The Best Investing Style After All(The 5 Minute Wrapup)

Nov 9, 2017

Even Buffett didn't always Buy and Hold forever. A look at Berkshire's 1992 and 2017 portfolios will tell you the story...

Large cap funds are more liquid(The Honest Truth)

Nov 6, 2017

Is the dangerous illiquidity risk in small-cap and mid-cap funds common to large-cap funds too?

You're Lucky You Missed Out on that IPO...(Smart Contrarian)

Nov 8, 2017

Here's how to profit from upcoming IPOs.

Your Last Chance to Trade ONLY the Best Stocks(Daily Profit Hunter)

Nov 11, 2017

Techno-Funda opportunities are knocking on your door. Are you ready to receive them?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Nov 17, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - ELDER PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS